An optimized background regimen design to evaluate the contribution of levofloxacin to multidrug-resistant tuberculosis treatment regimens: study protocol for a randomized controlled trial

Peer Review reports

Original Submission
11 Jan 2017	Submitted	Original manuscript
14 Sep 2017	Reviewed	Reviewer Report - Jean Joel Bigna
25 Sep 2017	Reviewed	Reviewer Report - Erik Cobo
12 Oct 2017	Author responded	Author comments - Tara Bouton
Resubmission - Version 2
12 Oct 2017	Submitted	Manuscript version 2
Publishing
30 Oct 2017	Editorially accepted
25 Nov 2017	Article published	10.1186/s13063-017-2292-x

Back to article page